Efficacy of telemedicine applications in patients with diabetic foot ulcers: A focus on mortality and major amputation rates

Basit Öğe Kaydı
dc.authoridYILDIRIM SIMSIR, ILGIN/0000-0002-6801-8499
dc.authoridvahabi, arman/0000-0002-8937-6658
dc.authoridCetinkalp, Sevki/0000-0001-6072-2062
dc.authoridmert, merve/0000-0002-5008-0139
dc.authorscopusid57221310487
dc.authorscopusid57208321979
dc.authorscopusid58338571400
dc.authorscopusid57489737700
dc.authorscopusid35574673900
dc.authorscopusid55750238100
dc.authorscopusid56496364100
dc.contributor.authorDemirkoparan, Mesut
dc.contributor.authorVahabi, Arman
dc.contributor.authorOzbek, Berker
dc.contributor.authorMert, Merve
dc.contributor.authorSimsir, Ilgin Yildirim
dc.contributor.authorErdem, Hueseyin Aytac
dc.contributor.authorOzturk, Anil Murat
dc.date.accessioned2024-08-25T18:47:39Z
dc.date.available2024-08-25T18:47:39Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractAmputations related to diabetic foot ulcers (DFU) are associated with high morbidity and mortality rates. Glycaemic control and close follow-up protocols are essential to prevent such ulcers. Coronavirus disease (COVID) related restrictions and regulations might have a negative impact on patients who are with DFU or candidates for DFU. We retrospectively analysed 126 cases that had DFU underwent amputation surgery. Comparative analyses were done between cases that were admitted before COVID restrictions (Group A) and cases admitted after COVID restrictions (Group B). Two groups were homogenic demographically. There was no significant difference between groups in terms of mortality (p = 0.239) and amputation rates (p = 0.461). The number of emergent cases in the pandemic period doubled the number in pre-pandemic period even though this finding was not statistically significant (p = 0.112). Fastly adapted consulting practice and follow-up protocols to compensate for the problems created by COVID-related regulations seem to be effective in terms of mortality and amputation rates.en_US
dc.identifier.doi10.1111/iwj.14283
dc.identifier.issn1742-4801
dc.identifier.issn1742-481X
dc.identifier.pmid37340728en_US
dc.identifier.scopus2-s2.0-85162631857en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1111/iwj.14283
dc.identifier.urihttps://hdl.handle.net/11454/101998
dc.identifier.wosWOS:001011622100001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofInternational Wound Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240825_Gen_US
dc.subjectamputationen_US
dc.subjectCOVID-19en_US
dc.subjectdiabetic foot ulceren_US
dc.subjectmortalityen_US
dc.subjectpandemicen_US
dc.subjectEpidemiologyen_US
dc.titleEfficacy of telemedicine applications in patients with diabetic foot ulcers: A focus on mortality and major amputation ratesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu